Molecular Nuclear Medicine with a 22' documentary from the history of radioactivity and cancer to the most modern Theragnostic
techniques, You will understand how SPECT and PET work, and how Radio Metabolic Therapy can treat cancer.
Multicenter, stratified, open, randomized, comparator controlled, parallel-group phase III study, comparing treatment with
177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in patients with inoperable, progressive, somatostatin receptor
positive Midgut Carcinoid Tumors.
Advanced Accelerator Applications (AAA) has a unique platform of laboratories for the research, development, production and distribution of radiopharmaceuticals for molecular diagnostics and therapy, aiming at a personalized treatment of serious diseases.